Chemapotheca LLC has a total of 14 patent applications. It decreased the IP activity by 80.0%. Its first patent ever was published in 2014. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets organic fine chemistry and pharmaceuticals are MEDICON PHARMACEUTICALS INC, PLACON THERAPEUTICS INC and KISS FRANTISEK.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Organic fine chemistry | |
#2 | Pharmaceuticals |
# | Name | Total Patents |
---|---|---|
#1 | Meckler Harold | 13 |
#2 | Yang Jie | 6 |
#3 | Popp Karl | 6 |
#4 | Gregg Brian Thomas | 4 |
#5 | Gregg Brian | 2 |
#6 | Suryadevara Praveen | 1 |
#7 | Cleary Darryl | 1 |
#8 | Brackeen Marcus | 1 |
Publication | Filing date | Title |
---|---|---|
WO2020180825A1 | Application for letters patent | |
EP3478363A1 | Amphetamine controlled release, prodrug, and abuse deterrent dosage forms | |
US2018243241A1 | Amphetamine controlled release, prodrug, and abuse-deterrent dosage forms | |
WO2015130660A1 | Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compounds | |
US2015183810A1 | Synthesis of racemic amphetamine derivatives by cuprate addition reaction with aziridine phosphoramidate compounds | |
US2015183716A1 | Synthesis of chiral amphetamine derivatives by stereospecific, regioselective cuprate addition reaction with aziridine phosphoramidate compounds |